Procyon Corp

PCYN Biotech & pharma

Develops wound care products for skin problems and ulcers.

Jun 2024Revenue $4.98M/yrExpenses $5.22M/yr
No trend
Figures by year

When will Procyon be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2024, revenue was $4.98M and expenses $5.22M.

Fiscal year toRevenueExpensesOperating profit
Jun 2024$4.98M$5.22M−$232K
Jun 2023$4.69M$4.78M−$97.4K
Jun 2022$4.84M$5.08M−$237K
Jun 2021$4.72M$4.49M$227K
Jun 2020$4.33M$4.18M$153K
Jun 2019$4.19M$4.09M$97.1K
Jun 2018$4.02M$3.89M$127K
Jun 2017$4.01M$3.98M$30.0K
Jun 2016$3.45M$3.55M−$104K
Jun 2015$2.77M$3.11M−$341K